ZeBlast is a pioneering biotechnology company that is revolutionising cancer drug discovery through cutting-edge research and innovation using zebrafish models.

We are proud to be the first biotech company to provide clinically relevant, off-the-shelf and validated zebrafish models to accelerate blood cancer drug developments.

ZeBlast takes an innovative approach by modelling blood cancers with distinct mutation combinations. We have successfully generated zebrafish carrying human blood cancer mutations, which developed the characteristic features of human diseases, including responses to drugs that target the specific mutations.

Traditionally, generation of transgenic zebrafish, particularly those carrying multiple transgenes, takes at least 2 years.  But ZeBlast takes a totally new approach where our products focus on blood cancer models which have been characterised to ensure faithful recapitulation of human diseases, making them available off-the-shelf for both industrial and academic customers to begin their drug discovery journal almost immediately.


Our services includes:

Innovative Transgenic Zebrafish Models
Chemical & Genetic Screening Services
Genetically Engineered Models
Contract & Commissioned Research
Zebrafish Breeding & Housing Services

For more information and to contact us please visit our website www.zeblast.com.hk

ZeBlast Technology Limited

Org chart

Teams

Offices